Share This

Related Topics News -

     
 Detail   |   Print    Next page > 
     
歌禮製藥治療銀屑病藥物ASC50獲美國批准I期新藥臨床試驗
2025-05-22T  
歌禮製藥ASC47-103研究完成首批受試者給藥
2025-05-20T  
歌禮製藥將公布肥胖症候選藥物ASC47早期研究結果
2025-05-06T  
歌禮製藥治療肥胖症藥物研究獲積極頂線結果
2025-04-23T  
歌禮製藥ASC30美國Ib期試驗取得積極期中結果
2025-03-31T  
《業績》歌禮製藥全年虧損擴至3.01億人民幣
2025-03-26T  
歌禮製藥治療肥胖症藥物獲美國FDA批准臨床試驗
2025-03-12T  
歌禮製藥飆升逾三成 減肥藥取得積極期中結果
2025-02-20T  
歌禮製藥ASC30美國Ib期研究取得積極期中結果
2025-02-20T  
歌禮製藥ASC30口服片美國Ia期研究取得積極成果
2025-01-21T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.